ArticleCancers2022

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer.

Samyuktha Suresh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.